TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
4/12/13 19:26 | 4/10/13 | ASTX | Astex Pharmaceuticals, Inc | DE | Health | Drug | Pharmaceutical Preparations | Molkentin Michael | CA | O | CFO | M.d | 12 | 1.65 | 0 | 8 | 39 | 26 | D | ||||||||||||||
5/20/11 14:57 | 5/19/11 | SUPG | Supergen Inc | DE | Health | Drug | Pharmaceutical Preparations | Molkentin Michael | CA | O | CFO | M.d | 8 | 1.65 | 0 | 5 | 45 | 16 | D | ||||||||||||||
5/16/08 17:21 | 5/15/08 | SUPG | Supergen Inc | DE | Health | Drug | Pharmaceutical Preparations | Molkentin Michael | CA | O | CFO | P | 1 | 2.57 | 0 | 0 | 5 | 5 | D | ||||||||||||||
4/2/08 20:46 | 3/31/08 | SUPG | Supergen Inc | DE | Health | Drug | Pharmaceutical Preparations | Molkentin Michael | CA | O | CFO | P | 7 | 2.69 | 0 | 3 | 200 | 4 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |